Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19

• Nobunao Ikewaki,
• Nobunao Ikewaki,
• Vidyasagar Devaprasad Dedeepiya,
• Masaru Iwasaki,
• Samuel J. K. Abraham,
• Samuel J. K. Abraham,
• Samuel J. K. Abraham,
• Samuel J. K. Abraham

Affiliations

Nobunao Ikewaki

Department of Medical Life Science, Kyushu University of Health and Welfare, Nobeoka, Japan

Nobunao Ikewaki

Institute of Immunology, Junsei Educational Institute, Nobeoka, Japan

Vidyasagar Devaprasad Dedeepiya

The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India

Masaru Iwasaki

School of Medicine, University of Yamanashi, Chuo, Japan

Samuel J. K. Abraham

The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India

Samuel J. K. Abraham

School of Medicine, University of Yamanashi, Chuo, Japan

Samuel J. K. Abraham

Edogawa Evolutionary Laboratory of Science (EELS), Edogawa Hospital, Tokyo, Japan

Samuel J. K. Abraham

Life-systems through Immunology, Phylogeny and Evolution (LIPE) Division, GN Corporation Co. Ltd., Kofu, Japan